E. Kukučková
Impact in
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 10%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
Papers in
-
- Bacterial Identification and Susceptibility Testing 10
- Oncology 18
- Neutropenia and Cancer Infections 18
E. Kukučková
20 papers receiving 297 citations
Peers
Comparison fields: 5 of 49
- Clinical Biochemistry 88
- Infectious Diseases 197
- Applied Microbiology and Biotechnology 20
- Molecular Medicine 32
- Epidemiology 165
Countries citing papers authored by E. Kukučková
This map shows the geographic impact of E. Kukučková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Kukučková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Kukučková more than expected).
Fields of papers citing papers by E. Kukučková
This network shows the impact of papers produced by E. Kukučková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Kukučková. The network helps show where E. Kukučková may publish in the future.
Co-authors
The 19 scholars most cited alongside E. Kukučková, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 13 | |
| 2 | 1998 | 82 | |
| 3 | 1998 | 9 | |
| 4 | 1997 | 16 | |
| 5 | 1997 | 17 | |
| 6 | 1997 | 33 | |
| 7 | 1997 | 7 | |
| 8 | 1997 | 16 | |
| 9 | 1996 | 3 | |
| 10 | 1996 | 18 | |
| 11 | 1996 | 1 | |
| 12 | 1996 | 23 | |
| 13 | 1996 | 3 | |
| 14 | Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. | 1996 | 8 |
| 15 | Bloodstream infections due to anaerobic bacteria in cancer patients: epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia. | 1996 | 11 |
| 16 | Breakthrough bacteraemic and fungaemic episodes during antimicrobial prophylaxis and therapy in cancer patients: analysis of risk factors, etiology, therapy and outcome in 123 episodes. | 1996 | 1 |
| 17 | Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. | 1996 | 11 |
| 18 | 1995 | 23 | |
| 19 | 1995 | 12 | |
| 20 | 1994 | 5 |
About E. Kukučková
E. Kukučková is a scholar working on Clinical Biochemistry, Oncology, Molecular Medicine, Infectious Diseases and Emergency Medical Services, having authored 21 papers that have together received 312 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (18 papers), Bacterial Identification and Susceptibility Testing (10 papers), Antifungal resistance and susceptibility (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Urinary Tract Infections Management (2 papers), Central Venous Catheters and Hemodialysis (2 papers), Fungal Infections and Studies (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Clinical Biochemistry (88 citations), Infectious Diseases (197 citations), Applied Microbiology and Biotechnology (20 citations), Molecular Medicine (32 citations) and Epidemiology (165 citations). E. Kukučková has collaborated with scholars based in Slovakia, Malaysia and United States. Frequent co-authors include S. Špánik, V. Krčméry, J. Trupl, E. Oravcová, A. Kunová, P. Pichňa, Ľuboš Drgoňa, Jozef Šufliarský, M Mrázová and Zdenka Jesenská. Their work appears in journals such as Chemotherapy, Supportive Care in Cancer, Journal of Chemotherapy, Infection and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.